Not logged in Share Save
Share Save
Non-adenocarcinoma histology in patients with RET plus lung cancer: Response to RET-inhibitors and survival from the RET-MAP registry Marinello, A.; Massa, G.; Rotow, J.; Bote De Cabo, H.; Monnet, I.; Guisier, F.; Duruisseaux, M.; Benitez Montanez, J. C.; Raimbourg, J.; Costa, J.; Tagliamento, M.; Feng, J.; Di Federico, A.; Metro, G.; Citarella, F.; Tabbo, F.; Lindsay, C.; Iranzo Gomez, P.; Besse, B.; Aldea, M. Share Save
Successive next-generation sequencing strategy for optimal fusion gene detection in non-small-cell lung cancer in clinical practice Garinet, Simon; Lupo, Audrey; Denize, Thomas; Loyaux, Romain; Timsit, Sarah; Gazeau, Benoit; Fabre, Elizabeth; Maaradji, Zineb; Gibault, Laure; Giroux-leprieur, Etienne; Duchemann, Boris; Monnet, Isabelle; Jouveshomme, Stephane; Aldea, Mihaela; Besse, Benjamin; Le Pimpec-barthes, Francoise; Leroy, Karen; Wislez, Marie; Blons, Helene Share Save
Immunohistochemistry expression of membrane targets for novel therapeutic agents in RET-rearranged NSCLC Marinello, Arianna; Ghigna, Maria Rosa; Zrafi, Wael Salem; Mandarano, Martina; Monnet, Isabelle; Genova, Carlo; Russo, Alessandro; Terrisse, Safae; Metro, Giulio; Remon, Jordi; Gazzah, Anas; Barlesi, Fabrice; Planchard, David; Scoazec, Jean-Yves; Besse, Benjamin; Aldea, Mihaela Share Save
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival Doubre, Helene; Monnet, Isabelle; Azarian, Reza; Girard, Philippe; Meyer, Guy; Trichereau, Julie; Devillier, Philippe; Van Dreden, Patrick; Couderc, Louis-Jean; Chouaid, Christos; Vasse, Marc Share Save
Clinical features of progression and outcomes with subsequent therapies in patients treated with RET-inhibitors Marinello, Arianna; Zrafi, Wael Salem; Massa, Giacomo; Tabbo, Fabrizio; Citarella, Fabrizio; Dall'Olio, Filippo Gustavo; Colin, Lindsay; Bria, Emilio; Metro, Giulio; Minatta, Jose Nicolas; Calles, Antonio; Monnet, Isabelle; Tagliamento, Marco; De Saint Basile, Hortense Gaultier; Girard, Nicolas; Pagliaro, Arianna; Cortinovis, Diego Luigi; Raimbourg, Judith; Zanchetta, Carol; Mountzios, Giannis; Nana, Frank Aboubakar; Terrisse, Safae; Russo, Alessandro; Iranzo, Patricia; Audigier-Valette, Clarisse; Rochigneux, Philippe; Fallet, Vincent; Duruisseaux, Michael; Cousin, Sophie; Guisier, Florian; Mezquita, Laura; Remon, Jordi; Gazzah, Anas; Planchard, David; Besse, Benjamin; Aldea, Mihaela Share Save
Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, combined with osimertinib, as first-line therapy or after progression on osimertinib in non-small cell lung cancer (NSCLC) Cappuzzo, F.; Moreno Garcia, V.; Ou, S-H. I.; Brandao, M.; Sanmamed, M. F.; Helissey, C.; Wislez, M.; Call, J. A.; Grisanti, S.; Johnson, M. L.; Boni, V.; Jamme, P.; Monnet, I.; Siena, S.; Yan, C.; Barasa, B.; Richard, B.; Joe, A. K.; Laus, G.; Felip, E. Share Save
Osimertinib in patients with EGFR-mutated NSCLC and leptomeningeal or brain metastases: Results of the IFCT-1804 ORBITAL trial Planchard, D.; Toffart, A. C.; Flandin, A-C. Madroszyk; Wislez, M.; Martinez, S.; Monnet, I.; Hiret, S.; Gounant, V.; Metivier, A-C.; Domblides, C.; Giroux-Leprieur, E.; Huchot, E.; Tomasini, P.; Mascaux, C.; Carmier, D.; Langlais, A.; Morin, F.; Westeel, V.; Cortot, A. Share Save
Relationship between tumor TP53 gene mutation, circulating anti-p53 antibodies and response to first-line osimertinib in EGFR-mutated NSCLC patients Denis, M. G.; Herbreteau, G.; Sagan, C.; Charpentier, S.; Vallee, A.; Cadranel, J.; Valette, C. Audigier; Tomasini, P.; Masson, P.; Pons-Tostivint, E.; Curcio, H.; Girard, N.; Cortot, A.; Molinier, O.; Monnet, I.; Marcq, M.; Urban, T.; Moro-Sibilot, D.; Lena, H.; Bennouna, J. Share Save
Prospective monitoring of autoimmune events in cancer immunotherapy patients: A report on the first 658 patients in the PRAISE study Sebbag, E.; Cloarec, N.; Monnet, I.; Najem, A.; Rajpar, S. L.; San, T.; Porneuf, M.; Barthelemy, P.; Rizzo, C.; Meunier, J.; Hamamouche, N.; Servy, H.; Desjeux, G.; Arnold, C.; Sauleau, E-A.; Chouaid, C.; Sedmak, N.; Gottenberg, J-E. Share Save
Share Save
Share Save
SrTiO3 surface micro-structuring with swift heavy ions in grazing incidence geometry Rahali, R.; Lebius, H.; Benyagoub, A.; Gardes, E.; Guillous, S.; Monnet, I.; Sall, M.; Chauvat, M. P.; Marie, D.; Grygiel, C. Share Save
Share Save
Share Save
Effectiveness of combination of osimertinib with another targeted therapy in advanced EGFR mutated non-small cell lung cancer harbouring other oncogenic drivers: The real-world COMPOSIT study Mehlman, C.; Swalduz, A.; Monnet, I.; Morin, C.; Guisier, F.; Curcio, H.; Du Rusquec, P.; Cortot, A.; Gounant, V.; Abbar, B.; Duchemann, B.; Giroux-Leprieur, E.; Pierret, T.; Quilot, F. M.; Cadranel, J.; Fallet, V. Share Save
GFPC 06-2018: A multicentre phase II, open-label, non-randomized study evaluating platinum-pemetrexedatezolizumab ( plus /- bevacizumab) for patients with stage IIIB/IV non-squamous NSCLC with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies Bylicki, O.; Gervais, R.; Monnet, I.; Ricordel, C.; Bigay-Game, L.; Geier, M.; Decroisette, C.; Daniel, C.; Guisier, F.; Swalduz, A.; Toffart, A. C.; Doubre, H.; Peloni, J. M.; Arpin, D.; Morel, H.; Veillon, R.; Clarisse, B.; Martins-Lavinas, P-H.; Greillier, L.; Chouaid, C. Share Save
COVID-19 disease among lung cancer (LC) patients: Data from a real-life prospective multicentric study Molinier, O.; Falchero, L.; Monnet, I.; Decroisette, C.; Neidhart, A-C.; Redureau, E.; Chiappa, A-M.; Bigot, F.; Bedossa, A.; Amrane, K.; Jeandeau, S.; Dujon, C.; Bugnet, A-S.; Bonnefoy, P.; Alizon, C.; Meyer, N.; Couraud, S.; Cortot, A.; Letierce, A.; Debieuvre, D. Share Save
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial Masip, J. Remon; Besse, B.; Ponce Aix, S.; Callejo, A.; Al-Rabi, K.; Bernabe Caro, R.; Greillier, L.; Majem Tarruella, M.; Reguart Aransay, N.; Monnet, I.; Cousin, S.; Lopez, P. Garrido; Robinet, G.; Garcia Campelo, M. R.; Flandin, A-C. Madroszyk; Mazieres, J.; Pretzenbacher, Y.; Fournier, B.; Dingemans, A-M. C.; Dziadziuszko, R. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
Share.png){kind=icon}
Save